Moreover, different studies in melanoma have revealed constitutively activated PI3K-AKT-mTOR (AKT) and RAF-MEK-ERK (MAPK) signalling pathways, which contribute to chemoresistance [44]. This evidence concerns the gene AKT1 and melanoma.